Abstract 1363: Identifying Blood Exosomal Mirnas As Biomarkers in the Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinoma
Shiwei Guo,Huan Wang,Hao Qin,Dadong Zhang,Zhuo Shao,Yanan Zhang,Bin Song,Xiaoya Xu,Jing Shen,Zishuo Chen,Xiaohan Shi,Suizhi Gao,Yaqi Pan,Fugen Li,Gang Jin
DOI: https://doi.org/10.1158/1538-7445.sabcs18-1363
IF: 11.2
2019-01-01
Cancer Research
Abstract:Purpose: Pancreatic ductal adenocarcinoma (PDAC) is of high mortality with a shortage of effective non-invasive biomarkers in the diagnosis and prognosis. Without a proper method to identify reasonable target molecules and their references for normalization, robust and accurate blood miRNA biomarkers have not been reported. We aim to explore the exosomal miRNAs as biomarkers for the diagnosis and prognosis of PDAC with sufficient biological insights and robustness. Materials and Methods: miRNA-seq was performed on miRNAs extracted from blood exosomes. 16 non-metastatic PDAC, 11 metastatic PDAC and 15 pancreatitis patients were enrolled in 2017 as the training set. Another 18 non-metastatic PDAC, 12 metastatic PDAC and 18 pancreatitis patients were enrolled in 2018 as the testing set. Bayesian network was built on the levels of miRNAs to identify candidate biomarkers with biological insights. The area under the curve (AUC) of receiver operating characteristic (ROC) was used to measure the accuracy of each pair of miRNAs. Results: The exosomal miRNA from the plasma of these patients with PDAC or pancreatitis has been successfully extracted and sequenced. The Bayesian network consisted of 337 nodes and 713 edges. The quotient of miR-95-3p (a “consequence” of “cancer”) over miR-26-5p (a “cause” of “pancreatitis”) performed 81.5% sensitivity and 93.3% specificity in the training cohort, and 86.7% sensitivity and 100% specificity in the testing cohort respectively. Furthermore, considering either high serum level of CA19-9 or the quotient of miR-95-3p/miR-26-5p as PDAC, the sensitivity increased to 96.5%, and the specificity was maintained at 96.9%. In addition, miR-335-5p level in blood exosome could predict metastasis with a mean accuracy of 77.2%, and showed strong relation with overall survival after surgeries. Conclusions: MiRNAs biomarkers from blood exosomes in differential diagnostics and prognosis are identified and rationale by Bayesian network. Integration of biomarkers of various molecular types could enhance the diagnostic accuracy beyond single molecular types. Blood exosomal miRNAs could be applied to monitor the development of PDAC. Citation Format: Shiwei Guo, Huan Wang, Hao Qin, Dadong Zhang, Zhuo Shao, Yanan Zhang, Bin Song, Xiaoya Xu, Jing Shen, Zishuo Chen, Xiaohan Shi, Suizhi Gao, Yaqi Pan, Fugen Li, Gang Jin. Identifying blood exosomal miRNAs as biomarkers in the diagnosis and prognosis of pancreatic ductal adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1363.